Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
diabetes mellitus 7 endocrinologydiseases
diabetic foot 4 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diabetes mellitus 3476 data are within the paper and its Supporting Information files.IntroductionThe global prevalence of diabetes mellitus (DM) has risen to 8.8% in 2015, which corresponds to 415 million patients [[1]]. This leads to increasing
diabetes mellitus 19180 extremity amputation; AR attributable risk; PAR population attributable risk; DD diabetes duration;DM diabetes mellitus ; ITDM insulin-treated diabetes mellitus; NITDM non-insulin–treated diabetes mellitus; PVD peripheral
diabetes mellitus 19220 risk; PAR population attributable risk; DD diabetes duration;DM diabetes mellitus; ITDM insulin-treated diabetes mellitus ; NITDM non-insulin–treated diabetes mellitus; PVD peripheral vascular disease;GLEAS Global Lower Extremity
diabetes mellitus 19267 duration;DM diabetes mellitus; ITDM insulin-treated diabetes mellitus; NITDM non-insulin–treated diabetes mellitus ; PVD peripheral vascular disease;GLEAS Global Lower Extremity Amputation Study [[46]].With regard to
diabetes mellitus 40568 extremity amputation; AR attributable risk; PAR population attributable risk; DD diabetes duration; DM diabetes mellitus ;ITDM insulin-treated diabetes mellitus; NITDM non-insulin-treated diabetes mellitus; IR incidence rate;
diabetes mellitus 40607 risk; PAR population attributable risk; DD diabetes duration; DM diabetes mellitus;ITDM insulin-treated diabetes mellitus ; NITDM non-insulin-treated diabetes mellitus; IR incidence rate; RR relative risks; Y year(s).* Incidence
diabetes mellitus 40652 diabetes duration; DM diabetes mellitus;ITDM insulin-treated diabetes mellitus; NITDM non-insulin-treated diabetes mellitus ; IR incidence rate; RR relative risks; Y year(s).* Incidence rates per 100,000 person years.† self-calculated.§
diabetic foot 2169 incidences of LEA in diabetic and non-diabetic patients are important for improvements in preventative diabetic foot care, avoidance of fatal outcomes, as well as a solid basis for health policy and the economy. However,
diabetic foot 3628 which corresponds to 415 million patients [[1]]. This leads to increasing numbers of individuals with diabetic foot disease, up to 75% of lower extremity amputations (LEAs) being performed in these patients [[2], [3]].
diabetic foot 52160 as smoking as well as by higher prevalence of peripheral vascular disease, peripheral neuropathy and diabetic foot ulceration [[35], [47]], but not by healthcare factors [[47]].Ethnic differences: Two studies, both
diabetic foot 55038 population could be explained in particular by better organised multidisciplinary care for patients with diabetic foot [[13], [16], [38]] but also by improvements in diabetes care [[13], [15], [19]], tighter control of

You must be authorized to submit a review.